Enzymatica AB (OSTO:ENZY) Other Current Assets: kr0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ENZY Enzymatica AB OSTO:ENZY
58 GF Score
Price kr1.90
GF Value kr2.12
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Enzymatica AB Other Current Assets?

Enzymatica AB OSTO:ENZY +2.70% 58 Other Current Assets is kr0.00 Mil as of Jun. 2026. GuruFocus rates OSTO:ENZY with a GF Score™ of 58/100 and a GF Value™ of kr2.12 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Enzymatica AB's other current assets for the quarter that ended in Jun. 2026 was kr0.00 Mil.

Enzymatica AB's quarterly other current assets declined from Dec. 2025 (kr2.35 Mil) to Mar. 2026 (kr0.00 Mil) but then stayed the same from Mar. 2026 (kr0.00 Mil) to Jun. 2026 (kr0.00Mil).

Enzymatica AB's annual other current assets increased from Dec. 2023 (kr6.44 Mil) to Dec. 2024 (kr6.52 Mil) declined from Dec. 2024 (kr6.52 Mil) to Dec. 2025 (kr2.35 Mil).


Enzymatica AB Other Current Assets Related Terms


Enzymatica AB Other Current Assets Historical Data

* Premium members only.

The historical data trend for Enzymatica AB's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzymatica AB Other Current Assets Chart

Enzymatica AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.80 4.94 6.44 6.52 2.35

Enzymatica AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 2.35 0.00 0.00
OSTO:ENZY
58GF Score
Enzymatica AB OSTO:ENZY
Other Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enzymatica AB Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Frequently Asked Questions Learn more about Other Current Assets →
What does a Other Current Assets of kr0.00 Mil mean?
Enzymatica AB (OSTO:ENZY) has a Other Current Assets of kr0.00 Mil as of Jun. 2026. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Enzymatica AB.
Is Enzymatica AB's Other Current Assets too high?
Enzymatica AB's current Other Current Assets is kr0.00 Mil. Overall, Enzymatica AB has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Enzymatica AB's Other Current Assets compare to ZTS?
Enzymatica AB's Other Current Assets of kr0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Assets for a Drug Manufacturers company?
A good Other Current Assets depends on the Drug Manufacturers industry context. However, Other Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Assets mean?
A high Other Current Assets can signal that a stock is expensive relative to its fundamentals. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Enzymatica AB. Enzymatica AB's current Other Current Assets is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enzymatica AB stock overvalued right now?
Based on GuruFocus' analysis, Enzymatica AB (OSTO:ENZY) is currently considered Modestly Undervalued. The stock's GF Value™ is kr2.12, compared to a current price of kr1.90 — trading 10.4% below its estimated fair value. The current Other Current Assets is kr0.00 Mil. Enzymatica AB's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Assets calculated?
Other Current Assets is calculated from a company's financial statements. For Enzymatica AB (OSTO:ENZY), the current Other Current Assets is kr0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Enzymatica AB (OSTO:ENZY) Overvalued in 2026?

Based on GuruFocus' analysis, Enzymatica AB stock appears to be undervalued. The current stock price of kr1.90 is trading 10.4% below its estimated GF Value™ of kr2.12. GuruFocus considers Enzymatica AB to be Modestly Undervalued.

Key valuation signals for OSTO:ENZY:

  • Other Current Assets: kr0.00 Mil
  • GF Value™: kr2.12 vs. price of kr1.90 (10.4% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the OSTO:ENZY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Enzymatica AB Business Description

Other Exchanges EN9:Germany
Address Scheelevagen 19, Delta 5, Ideon Science Park, Lund, SWE, SE-223 70
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.
58GF Score

Get the complete analysis for OSTO:ENZY

Other Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.90
Price
kr2.12
GF Value